The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

L.y

Gingival hypertrophy

Publications

Tejnani A, Mani A, Sodhi NK, Mehta A, Gourkhede S, Thorat V, Marawar P

Incidence of amlodipine-induced gingival overgrowth in the rural population of Loni.

Journal of Indian Society of Periodontology 2014 Mar;18;226-8 — 2014 Mar — 226-8

Breitung K, Remmerbach TW

[Gingival hyperplasia as side effect of the calcium channel blocker amlodipine].

Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia 2010;120;525-31 — 2010 — 525-31

Radwan-Oczko M, Boraty?ska M, Klinger M, Zietek M

Risk factors of gingival overgrowth in kidney transplant recipients treated with cyclosporine A.

Annals of transplantation 2003;8;57-62 — 2003 — 57-62